Dr Desiree Yap

23/04/2026

Discover free education resources for health professionals from Jean Hailes, including menopause programs and webinars.

23/04/2026

Keeping up with menopause care means staying close to the evidence as it evolves. The AMS newsletter is one reliable way to do that.

Each edition brings updates relevant to midlife women's health, alongside resources and professional development opportunities.

Subscribe to receive:
✅ Professional development opportunities like webinars, face-to-face events and eLearning
✅ Practical Information Sheets and Fact Sheets
✅ Menopausal Hormone Therapy (MHT) discontinuation and shortages updates

Start receiving updates today: https://zurl.co/lZtT0

16/04/2026

The AMS Menopause Essentials Update continues on the Gold Coast, presented in partnership with the Endocrine Society of Australia.

This focused half-day program of evidence-based education on midlife women's health and menopause management is targeted at endocrinologists seeking current, clinically relevant insights. The program offers clinical updates, expert guidance, and case-based learning to support your everyday practice.

Program Overview
🔹 The Menopause Consultation | Dr Melissa Katz
🔹 Prescribing Menopausal Hormone Therapy (MHT): Risk vs Benefit | Dr Hannah Farquhar
🔹 Non-hormonal Therapies | Dr Christina Jang
🔹 Prescribing MHT in Complex Situations | Dr Sonia Davison

🗓️ Friday, 8 May 2026
⏰ 09:00 am to 01:00 pm AEST
📍 QT Gold Coast
🔗 Registrations available to ESA Seminar 2026 attendees. Read more info here: https://zurl.co/iwHRS

This event is part of the Endocrine Society of Australia's annual scientific meeting, running from 8-10 May 2026 at QT Gold Coast, bringing together endocrinologists and health professionals for education, clinical updates, and professional connection. More info: https://zurl.co/I81sc

15/04/2026

📺 Explore the IMS YouTube Channel

🌎 The IMS YouTube channel brings together a wide range of expert-led content for both healthcare professionals and women.

📺 This includes:

👉Webinars with global experts
👉The Women’s Health Partnership Symposia Series
👉Sponsored symposia
👉Interviews with leading voices in menopause and midlife health
👉Council of Affiliated Menopause Societies (CAMS) Menopause Hour

Together, these resources offer evidence-based insights, support informed decision-making, and reflect the breadth of current thinking in menopause care.

🔗 Find all the videos and playlists here: https://www.youtube.com/

🔄 Follow us for insights and knowledge on menopause and midlife health from global experts.

14/04/2026

📖 Open Access Article - free for everyone to read

👉 Complementary therapies for management of menopausal symptoms: a systematic review to inform the update of the International Menopause Society recommendations on women’s midlife health

Menopausal hormone therapy is standard treatment, but some women use complementary therapies. This review examines complementary therapies for menopause to inform International Menopause Society (IMS) recommendations.

Authors: Alison Maunder, Amelia K. Mardon, Vibhuti Rao, Sophia Torkel, Najwa-Joelle Metri, Jing Liu, Guoyan Yang, et al.

Published online: 7th January 2026

🔗 https://doi.org/10.1080/13697137.2025.2584061

📚 Climacteric is the official journal of the International Menopause Society (IMS). As an international peer-reviewed journal it publishes original research and reviews of all aspects of aging in women. The IMS raises awareness and discussion of articles published, but doing so does not necessarily represent the IMS' position on a particular topic, approach or treatment

🔄 Follow us for insights and knowledge on menopause and midlife health from global experts.

12/04/2026

The Australian Coalition for Endometriosis 2026 National Endometriosis and Pelvic Pain Consultation is officially open!

Please go to the Endometriosis Coalition website to access the Discussion Paper and Survey.

This consultation is a comprehensive and inclusive forum designed to translate national priorities into effective, locally-relevant strategies. We urge patients, clinicians, researchers, and policymakers across all Australian jurisdictions to contribute their critical voice and expertise. Participants are encouraged to discuss current implementation gaps and unique challenges within their local communities and practice settings, and note any progress or concerns since the last roundtable consultations in 2025.

HAVE YOUR SAY by contributing in the following key ways:
- Celebrate Success: Share areas of progress and advancements in care, diagnosis, or policy implementation since the 2025 Roundtables.

- Suggest Something New: Propose innovative solutions and new strategic directions that will improve diagnosis, care, and quality of life for affected Australians.

- Explain a Barrier: Raise concerns or explain specific systemic and regional barriers preventing access to necessary care and support.

Please review the Discussion Paper: Informing the National Endometriosis Roundtable Consultations 2026 before responding to the survey, this can be found at the Endometriosis Coalition website.

CLOSING DATE FOR WRITTEN SUBMISSIONS: COB FRIDAY 1st MAY 2026.

To book an appointment and to share your feedback, please email:
Hello@Endocoalition.org.au

08/04/2026

The aim of this article is to provide GPs with a concise, evidence-based summary of the 2024 international POI guideline, focusing on diagnosis and management relevant to primary care.

08/04/2026

Chemotherapy and radiation therapy for cancer and other conditions can cause temporary or permanent loss of menstrual periods and menopause.

Before the age of 40, this is known as premature ovarian insufficiency (POI), and between the ages of 40 and 45, it is known as early menopause. Early menopause and POI can cause infertility and have short- and long-term health consequences such as heart disease, osteoporosis and memory problems.

The AMS fact sheet on Chemotherapy, Radiation Therapy and Menopause outlines diagnosis, fertility preservation options, hormone replacement therapy considerations, and management strategies for reducing health risks associated with POI and early menopause.

Download the fact sheet here: https://zurl.co/NUtKa

02/04/2026

As part of the publication of the IMS Recommendations and Key Messages on Women’s Midlife Health and Menopause, we are also pleased to highlight the accompanying Climacteric editorial.

Managing with Evidence: The International Menopause Society (IMS) recommendations
By Nick Panay (Lead Author of IMS Recommendations) and Tim Hillard (Editor-in-Chief, Climacteric)

At a time when women’s midlife health is finally receiving greater global attention, this editorial explores why high quality, evidence-based guidance matters more than ever.

It reflects on the role of international collaboration in strengthening menopause care and supporting informed, personalised approaches to health during the menopause transition and beyond.

Together, the Full Text Recommendations, the Climacteric Summary and Editorial mark an important step forward in advancing evidence-based menopause care worldwide.

Read the open access editorial here: https://www.imsociety.org/statements/ims-recommendations/

31/03/2026

Totally a thing.

For many women, a lifetime of putting others first quietly damages their health – and midlife is often when the cost finally becomes clear. https://ebx.sh/4SBQyW

26/03/2026

We are delighted to announce the publication of the IMS Recommendations and Key Messages on Women’s Midlife Health and Menopause.

Developed following a rigorous systematic review of the literature, these recommendations were formulated by an international writing group of 38 authors. Together, they provide evidence-based recommendations and key messages across 30 sections, covering lifestyle, midlife body changes, vasomotor symptoms, genitourinary syndrome of menopause, cardiometabolic health, bone health, cancers, dementia, premature ovarian insufficiency, sexual wellbeing, and more.

The overall aim of these recommendations and guidelines is to provide the blueprint for the management of women’s midlife health and menopause, given the latest available evidence.

An easily accessible summary of the recommendations and key messages was initially published in the December 2025 issue of Climacteric and has now been updated, alongside the accompanying Editorial. Both are free to access.

The full recommendations, including the detailed text, references, and supplementary materials, are available via the IMS website. This will function as a live document and be updated periodically as new evidence emerges and clinical practice advances, so you can always access the most up to date version.

This global effort was informed by stakeholder surveys, systematic reviews, expert interpretation, and multi-layer peer review and endorsement. The guidance aims to support clinicians in optimising evidence-based care at this critical stage of women’s lives.

Looking ahead, 2026 will feature expert-led webinars for clinicians and researchers, as well as an interview series hosted by Marla Shapiro C.M. with members of the writing group, exploring the recommendations in depth.

🔗 https://www.imsociety.org/statements/ims-recommendations/